Fraudulent Chargebacks from Unauthorized Transactions
Definition
In MCC 5122 wholesale drugs and sundries, wholesalers face chargebacks from customer disputes over unauthorized prescription transactions, fraud, or order discrepancies, which are harder to resolve due to the high-risk nature of pharmaceuticals. These reversed funds represent recurring revenue loss, compounded by elevated processing fees and reputational damage with payment processors. Mitigation requires full documentation and efficient dispute resolution, but systemic fraud exposure persists.
Key Findings
- Financial Impact: $High (due to reversal rates and processing fees in high-risk category)
- Frequency: Weekly
- Root Cause: Inadequate transaction authorization for sensitive prescription products, poor documentation of customer eligibility
Why This Matters
This pain point represents a significant opportunity for B2B solutions targeting Wholesale Drugs and Sundries.
Affected Stakeholders
Wholesaler Billing Specialists, Payment Processing Coordinators, Customer Service Reps
Action Plan
Run AI-powered research on this problem. Each action generates a detailed report with sources.
Methodology & Sources
Data collected via OSINT from regulatory filings, industry audits, and verified case studies.